Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov;25(11):3415-3419.
doi: 10.1111/dom.15213. Epub 2023 Jul 14.

Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study

Ernesto Maddaloni  1 , Angela Carlone  1 , Dario Pitocco  2 , Giulia Leanza  3 , Concetta Suraci  4 , Maria Altomare  4 , Maria G Cavallo  1 , Ilaria Barchetta  1 , Susanna Morano  1 , Chiara Moretti  1 , Lucia Coraggio  1 , Natalia Visalli  5 , Flavia Tramontana  3 , Riccardo Schiaffini  6 , Antonino Crinò  6 , Raffaella Buzzetti  1 , Paolo Pozzilli  3 ; IMDIAB study group
Collaborators, Affiliations

Glycated haemoglobin in the first year after diagnosis of type 1 diabetes is an independent risk factor for diabetic retinopathy: The IMDIAB 25 years follow-up study

Ernesto Maddaloni et al. Diabetes Obes Metab. 2023 Nov.
No abstract available

Keywords: HbA1c; metabolic memory; retinopathy; type 1 diabetes.

PubMed Disclaimer

References

REFERENCES

    1. Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, et al. The effect of intensive treatment of diabetes on the development and progression of long‐term complications in insulin‐dependent diabetes mellitus. N Engl J Med. 1993;329:977‐986. doi:10.1056/NEJM199309303291401
    1. Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long‐term follow‐up of the diabetes control and complications trial cohort. Diabetes Care. 1999;22(1):99‐111. doi:10.2337/diacare.22.1.99
    1. Lachin JM, Genuth S, Cleary P, Davis MD, Nathan DM. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med. 2000;342(6):381‐389. doi:10.1056/NEJM200002103420603
    1. Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group, Lachin JM, White NH, et al. Effect of intensive diabetes therapy on the progression of diabetic retinopathy in patients with type 1 diabetes: 18 years of follow‐up in the DCCT/EDIC. Diabetes. 2015;64(2):631‐642. doi:10.2337/db14‐0930
    1. The Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC study 30‐year follow‐up. Diabetes Care. 2016;39(5):686‐693. doi:10.2337/dc15‐1990

Publication types

MeSH terms

Substances

LinkOut - more resources